Tag: bms

March 18, 2020 Off

Oxford Biomedica, Juno Therapeutics in LentiVector deal

By Dino Mustafić

Oxford Biomedica has signed a new Licence and Clinical Supply Agreement (LSA) with Bristol-Myers Squibb’s company, Juno Therapeutics to use Oxford Biomedica’s LentiVector platform for its application in CAR-T and TCR-T programmes in oncology and other indications.

June 15, 2017 Off

BMS presents its Orencia related data

By Dino Mustafić

Bristol-Myers Squibb on Wednesday said it would present 23 abstracts related to Orencia (abatacept), including new data on the role of biomarkers and MRI in RA patient identification and treatment, at the Annual European Congress of Rheumatology (EULAR 2017) in Madrid, Spain.